Ensysce Biosciences, Inc. (ENSC) Shareholders’ equity 2020–2025
Ensysce Biosciences, Inc. (ENSC) shareholders’ equity at each fiscal year-end, per SEC filings.
$3.2MFY2025 · since FY2020: -$6.4M → $3.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.2M | -13.3% |
| FY2024 | $3.7M | +1248.6% |
| FY2023 | -$322,858 | +91.3% |
| FY2022 | -$3.7M | +52.9% |
| FY2021 | -$7.9M | -22.3% |
| FY2020 | -$6.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice